The fitness market under a new lens: why weight-loss pens are not a risk

The rise of pharmacological weight-loss therapies, such as GLP-1 pens, has sparked a necessary debate on the resilience of Brazil's premium service sector. Rather than threatening the business model of high-end gyms, industry leaders view this medical technology as a catalyst for new demand centered on body composition, shifting the focus from simple weight loss to lean muscle maintenance. This shift is crucial in a consumer landscape where the 12-month accumulated IPCA of 4.44% pressures household budgets, forcing wellness companies to deliver tangible value to retain clients. Regarding exchange rates, the commercial dollar at R$ 5.1625, down 0.46% in 30 days, impacts the import costs of fitness equipment and reflects external volatility. As the sector matures, gym chains are shifting from physical expansion to service integration. Despite risks like the 14% Selic rate affecting working capital, these medical interventions may ironically reduce churn, as users require specialized physical training to prevent muscle loss. Over the next 180 days, we expect sector consolidation, price adjustments to absorb inflation, and a focus on personalized data-driven health offerings to attract capital market interest.